The Valley Desk

NCT05733715 · Interventional trial

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Overall registry status Recruiting

Early Phase 1

Conditions Renal Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov